EUR/USD 1.1535 ▼ 0.14%GBP/USD 1.3482 ▼ 0.14%USD/JPY 154.8122 ▲ 0.30%USD/CHF 0.8178 ▲ 0.06%EUR/CHF 0.9433 ▼ 0.09%BTC/USD 77,038.3 ▼ 1.47%ETH/USD 2,475.26 ▼ 1.61%SOL/USD 100.92 ▼ 1.57%XAU/USD 4,274.82 ▼ 0.55%EUR/USD 1.1535 ▼ 0.14%GBP/USD 1.3482 ▼ 0.14%USD/JPY 154.8122 ▲ 0.30%USD/CHF 0.8178 ▲ 0.06%EUR/CHF 0.9433 ▼ 0.09%BTC/USD 77,038.3 ▼ 1.47%ETH/USD 2,475.26 ▼ 1.61%SOL/USD 100.92 ▼ 1.57%XAU/USD 4,274.82 ▼ 0.55%
Finance Review DailyMARKETS • BUSINESS • ECONOMY
EILMELDUNG
Oil Prices Surge Over 4% to 16-Week High on Saudi Strikes and Gulf-Tensions•Federal Reserve expected to raise rates under Chairman Kevin Warsh as oil tops $100 a barrel•Zevra Therapeutics Sees Rare-Disease Market as $30M+ Per-Quarter Opportunity•Loonie Holds Near 12-Day Low as Oil Support Fails to Offset Dollar Strength•Radiant Logistics Q4 Earnings Top Estimates, Shares Jump 6.8%•Oil Prices Surge Over 4% to 16-Week High on Saudi Strikes and Gulf-Tensions•Federal Reserve expected to raise rates under Chairman Kevin Warsh as oil tops $100 a barrel•Zevra Therapeutics Sees Rare-Disease Market as $30M+ Per-Quarter Opportunity•Loonie Holds Near 12-Day Low as Oil Support Fails to Offset Dollar Strength•Radiant Logistics Q4 Earnings Top Estimates, Shares Jump 6.8%•
ADVERTISEMENT
LIVE-DESK·Globale Marktredaktion·Last updated 14s ago
ADVERTISEMENT
Märkte/AktienArticle

LB Pharmaceuticals names Susan Kozauer as chief medical officer

LB Pharmaceuticals announced the appointment of Susan Kozauer as its chief medical officer.

PA
Priya Anand · Equities & Earnings Desk · 15 Sept 2026 · 17:29 · 1 Min. Lesezeit
Teilen
LB Pharmaceuticals names Susan Kozauer as chief medical officer

LB Pharmaceuticals has appointed Susan Kozauer as its chief medical officer.

Further details about the appointment were not immediately available.

Equities
Dieser Artikel wurde mit KI-Unterstützung erstellt und von einer Finances-Review-Redakteurin bearbeitet.
ADVERTISEMENT
Artikel teilen
PA
Geschrieben von
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

Mehr von Priya Anand →
ADVERTISEMENT

Marktüberblick

Verzögert
EUR/USD1.1535▼ 0.14%GBP/USD1.3482▼ 0.14%USD/CHF0.8178▲ 0.06%BTC/USD77,038.3▼ 1.47%ETH/USD2,475.26▼ 1.61%XAU/USD4,274.82▼ 0.55%

Das könnte Sie auch interessieren

Teradyne director sells $56,997 of shares after record quarter
Aktien

Teradyne director sells $56,997 of shares after record quarter

Priya Anand · vor 4 Min.
ADVERTISEMENT